Stock News and Filings Feed


Add 524816
to your dashboard

BSE Healthcare index down 1.60%; Natco Pharma top loser

2017-08-18 indiainfoline
The BSE Healthcare index was witnessing a southward rally during Friday’s trade. The index was down by over 1.50%, while Natco Pharma was the top loser of the index.

Natco Pharma Limited - Updates

2017-08-16 feedproxy.google

Natco Pharma lines up 10 new products for domestic market

2017-08-14 thehindubusinessline
Natco Pharma will be launching about 10 new products in the domestic branded formulations segment in the present financial year and is targeting over 20 per cent growth year-on-year.

USFDA nod may boost Natco Pharma

2017-08-14 thehindubusinessline
Natco Pharma on Monday said it has received approval from the USFDA to market Lanthanum Carbonate chewable tablets used in the treatment of patients with end-stage renal disease. Its first generic product will be launched in the US soon. Fosrenol tablets had sales of $122.4 million during June 2017 in the US.

Natco Pharma gets USFDA nod for Lanthanum Carbonate Tablets

2017-08-14 indiainfoline
Natco Pharma announced on Monday that the company has received the final approval of Abbreviated New Drug Application (ANDA) from the US Food and Drug Administration (USFDA) for Lanthanum Carbonate Chewable Tablets 500 mg (base), 750 mg (base), and 1000 mg (base).

Natco Pharma gets USFDA nod for generic renal disease drug

2017-08-14 thehindubusinessline
Natco Pharma Ltd has received final nod from the US Food and Drug Administration (FDA) for Abbreviated New Drug Application (ANDA) for lanthanum carbonate chewable tablets.

Natco gets US FDA nod to market renal disease drug

2017-08-14 thehindubusinessline
Natco Pharma today said it has received approval from the US health regulator to market Lanthanum Carbonate chewable tablets used in treatment of patients with end stage renal disease.

Natco gets USFDA nod to market renal disease drug

2017-08-14 moneycontrol
Natco Pharma today said it has received approval from the US health regulator to market Lanthanum Carbonate chewable tablets used in treatment of patients with end stage renal disease.

Natco shares gain on getting final approval for kidney drug

2017-08-14 moneycontrol
Natco Pharma on Monday said it got final approval for generic Lanthanum Carbonate chewable tablets of 500 mg (base), 750 mg (base), and 1000 mg (base) dosage forms.

Natco Pharma Limited - Press Release

2017-08-14 feedproxy.google

Market Week Ahead: After 1,112-pt Sensex correction, keep an eye on these 10 factors

2017-08-13 moneycontrol
The market snapped a five-week winning streak and fell sharply by more than 1,100 points on the Sensex, weighed by geopolitical tensions surrounding around North Korea and disappointing earnings.

Pharma weekly wrap: Pharma stocks had tough week due to GST and pricing pressures in US

2017-08-12 moneycontrol
For pharmaceutical stocks, this past week was one of the worst - many have sunk on weak Q1 results due to destocking of channel on account of GST rollout and US pricing pressures. The weak global cues also didn't help the matters.

Natco Pharma extends loss over 15% on Thursday

2017-08-10 indiainfoline
Pharma major, Natco Pharma extends losses to over 15% from the early morning trade on Thursday on the BSE.

Natco shifts focus from US to India amidst pricing pressure and competition in former market

2017-08-10 moneycontrol
In a radical shift in strategy drug maker Natco Pharma said it will throw more capital and R&D resources towards generic filings in India and Rest-of-the-World (RoW) markets over US citing heavy competition and pricing pressure.

Natco Pharma extends losses, down 11% after Q1 earnings, Bhujanga Rao resigns

2017-08-09 moneycontrol
Natco Pharma plunged more than 11 percent intraday Wednesday despite strong set of earnings in Q1FY18. The sharp fall was led by end of large Tamiflu generic contribution to US business and resignation from director & president of R&D and tech division. The stock lost 4 percent in previous session.

Live Stock Market Updates Market at days low

2017-08-08 indiainfoline
The INDIA VIX is up 3% at 12.2. The S&P BSE Sensex is trading at 32,179 down 94 points, while Nifty is trading at 10,030 down 26 points.

Nifty Bank down over 1%; PNB top loser

2017-08-08 indiainfoline
The Nifty Bank was lagging during early morning trade on Tuesday, it was trading down by over 1%. Punjab National Bank was the top loser, down by 2.40% at Rs 148.45 per share as at 1006 hours.

Govt to float RFP for Air India disinvestment

2017-08-08 indiainfoline
The government will soon float a request for proposal (RFP) for selection of transaction advisor, legal advisor as well as asset valuer for the proposed disinvestment of Air India as per a leading news daily.

Natco Pharma’s Q1 net up 97%

2017-08-07 thehindubusinessline
Natco Pharma Ltd’s consolidated net profit increased 97 per cent to ₹94 crore in the first quarter ended June 30, 2017, compared to ₹47.5 crore in the corresponding quarter of the previous financial year. The revenue of the Hyderabad-based company grew 30 per cent to ₹449 crore ( ₹345.5 crore). When contacted, M Adinarayana, Vice-President, Natco Pharma, told Business Line that the growth in revenue and profit was driven by positive impact of hepatitis combination products, Tamiflu besides new launches in diabetology and cardiology segments.

Natco Pharma’s Q1 profit after tax up 97% at Rs94 crore

2017-08-07 livemint
Hyderabad: Natco Pharma Ltd on Monday said its consolidated profit after tax for the quarter ended 30 June was up by 97% to Rs94 crore.

Natco Pharma announces interim dividend

2017-08-07 indiainfoline
The board of directors of pharma major Natco Pharma approved the recommended payment of an interim dividend in its meeting held on Monday, informed the company in a BSE filing.

Natco Pharma Q1 profit doubles to Rs 97.3 cr led by generic Tamiflu exclusivity in US

2017-08-07 moneycontrol
Natco Pharma on Monday posted two-fold increase in net profit to Rs.97.3 crore in first quarter ended June partly on back of exclusivity of generic Tamiflu drug in the US market.

Broader markets outperform, Midcap up 1%; Sensex closes lower; Tata Steel up 4%

2017-08-07 moneycontrol
Equity benchmarks closed a rangebound session with marginal losses but the broader markets outperformed, with the BSE Midcap and Smallcap indices rising 1 percent on Monday.

Natco Pharma Limited - Press Release

2017-08-07 feedproxy.google

Fintel IR - Find the Right Investors for Your Company, Instantly!

Fintel IR combines the comprehensive Fintel ownership database with machine learning to provide advanced tools to make investor outreach fast and easy. Learn more now!